|
ISOLATION AND USE OF SOLID TUMOR STEM CELLS |
|
用于乳腺癌的预后的方法和试剂盒 |
|
|
|
|
|
|
|
Trapped key mechanism |
|
Method and composition for cancer detection in humans |
|
Recombinant immunoglobin preparations |
|
Apparatus and method for performing immunoassays |
|
Single polypeptide chain binding molecules |
|
Method of making a brush |
|
Directed evolution of novel binding proteins |
|
Intermediates for conjugation of polypeptides with high molecular weight polyalkylene glycols |
|
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
|
Transgenic non-human animals capable of producing heterologous antibodies |
|
Ransgenic non-human animals for producing heterologous antibodies |
|
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
|
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
|
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
|
Automated continuous and random access analytical system |
|
Immunoassays for prostate specific antigen |
|
Fluorescent energy transfer immunoassay |
|
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
|
Production of chimeric antibodies - a combinatorial approach |
|
Production of antibodies from transgenic animals |
|
Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
|
Transgenic non-human animals for producing heterologous antibodies |
|
Method for making heteromultimeric polypeptides |
|
Low pH hydrophobic interaction chromatography for antibody purification |
|
Humanized antibodies and methods for making them |
|
Immunoassays for prostate specific antigen |
|
Adjuvant incorporation into antigen carrying cells: compositions and methods |
|
Implanted tumor cells for the prevention and treatment of cancer |
|
Humanized immunoglobulins |
|
Methods for fabricating microarrays of biological samples |
|
Humanized immunoglobulins and methods of making the same |
|
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
|
Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
|
Fluorescence polarization immunoassay diagnostic method |
|
Fluorometric detection using visible light |
|
Automated immunoassay analyzer |
|
Isolation and use of solid tumor stem cells |
|
Hybrid antibodies and uses thereof |
|
Isolation and use of solid tumor stem cells |
|
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
|
Anti-interleukin 8 therapy for tumor osteolysis |
|
Methods and compositions for treating and preventing tumors |
|
IL-8 receptor antagonists |
|
Determining the capability of a test compound to affect solid tumor stem cells |
|
ALDH1 As A Cancer Stem Cell Marker |
|
Breast tumor treatment with anti-CXCR1 compositions |
|
ANTI-CXCR1 COMPOSITIONS AND METHODS |
|
|
|
INTERACTION TRAP SYSTEM FOR ISOLATING NOVEL PROTEINS |
|
PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS |
|
ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS |
|
COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER |
|
DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH CXC CHEMOKINE RECEPTOR 1 (CXCR1) |
|
COMPOSITIONS AND METHODS FOR CHARACTERIZING, REGULATING, DIAGNOSING, AND TREATING CANCER |
|
CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS |
|
COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER |
|
ALDEHYDE DEHYDROGENASE 1(ALDH1) AS A CANCER STEM CELL MARKER |
|
COLON STEM CELLS ASSOCIATED WITH COLITIS AND COLORECTAL CANCER AND METHODS OF USE |
|
ANTI-CXCR1 COMPOSITIONS AND METHODS |